Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
34.35%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.7M | 34.35% | $ 10.77M |
| 3/31/2025 | $ 6.8M | 34.07% | $ 19.96M |
| 12/31/2024 | $ 8.32M | 42.36% | $ 19.63M |
| 9/30/2024 | $ 10.34M | 51.01% | $ 20.27M |
| 6/30/2024 | $ 10.68M | 51.55% | $ 20.71M |
| 3/31/2024 | $ 9.28M | 61.59% | $ 15.07M |
| 12/31/2023 | $ 8.27M | 55.4% | $ 14.92M |
| 9/30/2023 | $ 6.18M | 58.15% | $ 10.63M |
| 6/30/2023 | $ 4.1M | 8.77% | $ 46.8M |
| 3/31/2023 | $ 2.04M | 4.71% | $ 43.24M |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 1.31%.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average DepAmor % has been 20.41%.
- The median DepAmor % for CARISMA THERAPEUTICS INC during this period was 3.15%
- CARISMA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 61.59%.
- The lowest DepAmor % recorded by CARISMA THERAPEUTICS INC in the same timeframe 0.03%
CARISMA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for CARISMA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 147K ] / Revenues [ $ 11.24M ]
(=) DepAmor % [ 1.31% ] CARM - Depreciation and Amortization Margin, Last 5 years
0.03%
Minimum
Dec 31, 2022
61.59%
Maximum
Mar 31, 2024
20.41%
Average
3.15%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |